· Tarceva Patent Re-issue Application: OSI Pharmaceuticals, Inc. filed an application to reissue US Patent No. 5,747,498 for Erlotinib, the active ingredient in anti-cancer drug Tarceva. Read.
· Genentech Patent for Cabilly rejected fourth time: United States Patent & Trademark Office has issued rejection action against Genentech’s Cabilly patent. Read.
· Sun Pharma Challenged J&J Drug patent: Sun Pharmaceuticals filed a post-grant opposition against Janssen’s Risperidone extended release version. Read.
· MNCs’ Diabetes Drug Patents Worry Experts: Business Standard reports exclusive story over diabetes drug patents in
· Barr Challenge Glaxo’s Prostate Drug Avodart: Barr made paragraph IV certification for Glaxo prostate drug Avodart, generically known as dutasteride. Read.